PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
November 23, 2011 | ISSUE NUMBER 227 VOL 8

Strategy
The Real Way to Lean Success: Suck Out Your IT Fat!
Bill Drummy argues why it’s essential to cut out any non-essential IT process and stop obsessing about the trivial—that means stop talking about social media! Instead, implement programs that deliver the ability to see farther and move faster ...Read More

Pricing
Tiered Pricing Not Always a Win-Win
Tiered pricing, or selling critical medicines to developing countries at a standardized discount price, can improve access in the short term, but arbitrary demographic groupings and misaligned incentives often stack the deck in favor of manufacturers, not patients, a new report finds ...Read More

Europe
Election Landslide in Spain: What Now for Healthcare?
As predicted, the conservative Popular Party swept to victory in Spain at the weekend amidst the country’s worsening debt crisis and staggering levels of unemployment. So what does the new government plan to do for the health system? ...Read More

World Health
One in Ten Adults Diabetic by 2030
According to International Diabetic Federation figures, the number of people living with diabetes could rise from 366 million in 2011 to 552 million by 2030, if preventative measures are not considered. That equates to three new cases every 10 seconds, or almost 10 million each year ...Read more

// Liaison Technologies (Atlanta, Ga.) appointed Clark Golestani to its Board of Directors. // Christian Tucat was appointed Vice President & General Manager, Europe Middle East & Africa at Theorem Clinical Research (previously Omnicare Clinical Research, King of Prussia, Pa.) // Cerenis Therapeutics (Ann Arbor, Mich. and Toulouse, France) appointed Dr. Richard C. Pasternak to its Board of Directors. John F. Paolini also became the company's Chief Medical Officer. // The International Society for Pharmaceutical Engineering (ISPE; Tampa, Fla.) announced its 2011 awards at its Annual Meeting in Grapevine, Tex. Among the winners were Michael A. Arnold, RPh (Max Seales Yonker Member of the Year); Shinichi Osada and Jane Brown (Richard B. Purdy Distinguished Achievement Award); and Pfizer (Company of the Year).

Nov. 30–Dec. 2: Therapeutic Area Partnerships
Boston, MA


Dec. 5–6: FT Global Pharmaceutical and Biotechnology Conference 2011
London, UK


Dec. 5–8: KOL & Stakeholder Engagement USA 2011
Philadelphia. PA


Dec. 9: Key Influencers and their Networks in Hematology
San Diego, CA


Feb. 28–29: Global Transparency Congress
London, UK



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
 


 
Survey
Which country do you think will offer the most significant growth prospects over the next 3 years?
Click To Vote
 
Quick Links

GSK Establishes $50-billion Innovation Fund in Canada

FDA Approves 35 Novel Medicines in 2011

FDA Revokes Breast Cancer Indication for Avastin


User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

 
Visit Pharmaceutical Executive